CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression and an indolent clinical course
Modern Pathology Oct 13, 2017
Hu Z, et al. - This research was executed in order to comprehensively investigate the role of CD200 expression in mantle cell lymphoma. Despite being an uncommon entity, CD200 expression in mantle cell lymphoma detected a subgroup of mantle cell lymphoma patients with characteristic pathological features, frequent non-nodal leukemic variant and an indolent clinical course.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
